QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Trial details
- Registry ID
- NCT02465957
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)NCT02465957 | IBRX | Phase 2 | Terminated | 2018-03-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |